{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:46:42Z","timestamp":1760622402844},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ijantimicag.2003.09.012","type":"journal-article","created":{"date-parts":[[2004,1,31]],"date-time":"2004-01-31T10:17:01Z","timestamp":1075544221000},"page":"129-137","source":"Crossref","is-referenced-by-count":27,"title":["Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis"],"prefix":"10.1016","volume":"23","author":[{"given":"I","family":"Starakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Bassaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2003.09.012_BIB1","doi-asserted-by":"crossref","first-page":"380S","DOI":"10.1378\/chest.117.5_suppl_2.380S","article-title":"Infectious exacerbations of chronic bronchitis","volume":"117","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB2","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1378\/chest.108.2_Supplement.43S","article-title":"Epidemiology and treatment of chronic bronchitis and its exacerbations","volume":"108","author":"Ball","year":"1995","journal-title":"Chest"},{"issue":"Suppl A","key":"10.1016\/j.ijantimicag.2003.09.012_BIB3","first-page":"40A","article-title":"Management of acute exacerbations of chronic bronchitis","volume":"6","author":"Grossman","year":"1999","journal-title":"Can. Respir. J."},{"issue":"Suppl A","key":"10.1016\/j.ijantimicag.2003.09.012_BIB4","first-page":"32","article-title":"Acute exacerbations of chronic bronchitis: fluoroquinolone clinical trial review","volume":"16","author":"Anzueto","year":"1999","journal-title":"Infect. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/srin.2000.0150059","article-title":"Antibiotic therapy of exacerbations of chronic bronchitis","volume":"15","author":"Niederman","year":"2000","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.273.12.957","article-title":"Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis","volume":"273","author":"Saint","year":"1995","journal-title":"J. Am. Med. Assoc."},{"issue":"Suppl A","key":"10.1016\/j.ijantimicag.2003.09.012_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/38.suppl_A.1","article-title":"A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992\u20131993: the Alexander Project","volume":"38","author":"Felmingham","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199408113310607","article-title":"Management of infections caused by antibiotic resistant Streptococcus pneumoniae","volume":"331","author":"Friedland","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.28.2.357","article-title":"Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children\u2019s hospital in Barcelona, Spain","volume":"28","author":"Latorre","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/infdis\/163.3.542","article-title":"Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary","volume":"163","author":"Marton","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/clinids\/21.6.1398","article-title":"Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany 1992\u20131994","volume":"21","author":"Reinert","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239474","article-title":"In vitro activity of Bay 12-8039 a new 8-methoxyquinolone","volume":"42","author":"Dalhoff","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/AAC.42.8.2060","article-title":"Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxyquinolone, administered to healthy subjects","volume":"42","author":"Stass","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1993","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ijantimicag.2003.09.012_BIB16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM199701303360502","volume":"336","author":"Adkinson","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijantimicag.2003.09.012_BIB17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0197-2456(01)00207-0","article-title":"Randomized, placebo controlled, parallel group versus crossover study design for the study of dementia in Parkinson\u2019s disease","volume":"23","author":"Putt","year":"2002","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European respiratory society task force","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur. Respir. J."},{"issue":"Suppl A","key":"10.1016\/j.ijantimicag.2003.09.012_BIB19","first-page":"8","article-title":"Role of antimicrobials in the management of acute exacerbations of chronic bronchitis","volume":"16","author":"Chodosh","year":"1999","journal-title":"Infect. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02768764","article-title":"Randomized comparison of once-daily ceftibuten and twice daily clarithromycin in the treatment of acute exacerbations of chronic bronchitis","volume":"26","author":"Ziering","year":"1998","journal-title":"Infection"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2003.09.012_BIB21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2165\/00003495-199500492-00129","article-title":"Causative organisms in acute exacerbation of chronic airways disease and response to ofloxacin therapy","volume":"49","author":"Sufarlan","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1179\/joc.1995.7.5.432","article-title":"Comparative evaluation of the clinical and microbiological efficacy of the co-amoxiclav versus cefixime or ciprofloxacin in the bacterial exacerbation of chronic bronchitis","volume":"7","author":"Cazzola","year":"1995","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.1998.tb11633.x","article-title":"Short-course cefuroxime axetil therapy in the treatment of exacerbations of chronic bronchitis","volume":"52","author":"Langan","year":"1998","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jac\/44.4.501","article-title":"Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis","volume":"44","author":"Wilson","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.42.4.772","article-title":"Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa","volume":"42","author":"Monso","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.09.012_BIB26","unstructured":"Ferguson J, Al-Ajmi H, Kubin R, Daggett S, Saggu PS. A double-blind, placebo and lomefloxacin controlled human volunteer study to determine the photosensitizing potential of oral moxifloxacin (Bay 12-8039). In: Program and Abstracts of the Eighth International Congress of Infectious Diseases, International Society for Infectious Diseases, Boston, USA, 1998. Abstract 59.001. p. 197."},{"issue":"7","key":"10.1016\/j.ijantimicag.2003.09.012_BIB27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1742-1241.2001.tb11086.x","article-title":"The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience","volume":"55","author":"Miravitlles","year":"2001","journal-title":"Int. J. Clin. Pract."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T02:59:19Z","timestamp":1705028359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903003984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0924857903003984"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.09.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}